- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07614386
Radial Access Data in Vascular Interventions Registry (RADIUS)
Radial Access Data in Vascular Interventions: A Prospective Observational Registry Study
The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated with transradial and transulnar vascular access.
Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled. Demographic, clinical, angiographic, procedural, and post-procedural data will be prospectively collected and analyzed.
The study was initially designed as a single-center registry; however, following Institutional Review Board (IRB) approval, expansion into a multicenter registry with participating centers is planned.
This study is observational in nature and does not involve any experimental treatment, device, or intervention beyond standard clinical care.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The RADIUS (Radial Access Data in Vascular Interventions) study is a prospective observational registry designed to systematically collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions.
Transradial access has become increasingly preferred in contemporary interventional practice because of lower bleeding risk, improved patient comfort, earlier mobilization, and reduced vascular complications compared with traditional femoral access. In addition, transulnar access has emerged as an alternative vascular access strategy in selected patients. Despite the increasing adoption of radial and ulnar access techniques, comprehensive real-world registry data evaluating procedural characteristics, vascular complications, procedural success, and clinical outcomes remain limited.
The RADIUS registry aims to evaluate demographic, clinical, angiographic, procedural, and post-procedural characteristics of patients undergoing percutaneous vascular interventions through radial or ulnar artery access. Particular focus will be placed on access-site complications, including radial artery spasm, radial artery occlusion, bleeding complications, crossover to alternative access sites, vascular injury, and short-term clinical outcomes.
The study will enroll consecutive adult patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital between May 2026 and May 2031. Data will be prospectively collected from procedural reports, hospital electronic medical records, and routine clinical evaluations.
Collected variables will include demographic characteristics, cardiovascular risk factors, comorbidities, laboratory findings, angiographic and procedural details, vascular access characteristics, procedural duration, fluoroscopy time, contrast volume, devices and techniques used during procedures, procedural success rates, and in-hospital and short-term complications.
The study was initially designed as a single-center registry; however, expansion into a multicenter registry involving additional participating centers is planned following Institutional Review Board (IRB) approval and local regulatory processes.
This registry is purely observational in nature and does not involve any experimental drug, device, or intervention beyond standard clinical care. All procedures and treatment strategies will be performed according to current routine clinical practice and operator discretion.
Data obtained from the registry will be analyzed using appropriate statistical methods, and the results are expected to contribute to the understanding and optimization of radial and ulnar access strategies in vascular interventions and support future scientific publications.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Sefa SURAL, MD
- Telefonnummer: +90 532 565 01 60
- E-Mail: sesural@hotmail.com
Studieren Sie die Kontaktsicherung
- Name: Gökhan AVCI, MD
- Telefonnummer: +90 506 228 57 09
- E-Mail: drgavci@hotmail.com
Studienorte
-
-
Mezitli
-
Mersin, Mezitli, Türkei (türkiye), 33010
- Rekrutierung
- Mersin Medicalpark hospital
-
Kontakt:
- Sefa Sural, MD
- Telefonnummer: +905325650160
- E-Mail: sesural@hotmail.com
-
Kontakt:
- Gökhan AVCI, MD
- E-Mail: drgavci@gmail.com
-
Unterermittler:
- Vedat ASLAN, MD
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Age ≥18 years
- Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access
- Ability to provide informed consent
Exclusion Criteria:
- Age <18 years
- Procedures performed without radial or ulnar artery access
- Incomplete procedural or clinical data
- Refusal to participate in the registry
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Radial and Ulnar Access Registry Cohort
Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access.
|
Routine percutaneous vascular interventions performed via radial or ulnar artery access according to standard clinical practice.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Radial Artery Occlusion Rate
Zeitfenster: Within 1 year after procedure
|
Incidence of radial artery occlusion following percutaneous vascular interventions performed via radial artery access.
|
Within 1 year after procedure
|
|
Access-Site Vascular Complication Rate
Zeitfenster: through study completion, an average of 1 year
|
Incidence of vascular access-site complications including bleeding, hematoma, pseudoaneurysm, arterial dissection, and vascular injury.
|
through study completion, an average of 1 year
|
|
Radial Artery Spasm Rate
Zeitfenster: During Procedure
|
Incidence of clinically significant radial artery spasm during or immediately after the procedure.
|
During Procedure
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Procedural Success Rate
Zeitfenster: During procedure
|
Successful completion of the planned vascular intervention using radial or ulnar artery access without crossover to alternative access.
|
During procedure
|
|
Crossover Rate
Zeitfenster: During Procedure
|
Need for conversion from radial or ulnar access to another vascular access site during the procedure.
|
During Procedure
|
|
Bleeding Complications
Zeitfenster: During Procedure
|
Incidence of access-site or non-access-site bleeding complications following the procedure.
|
During Procedure
|
|
Fluoroscopy Time
Zeitfenster: During Procedure
|
Total fluoroscopy time during the procedure, measured in minutes.
|
During Procedure
|
|
Length of Hospital Stay
Zeitfenster: From the date of vascular intervention until hospital discharge, assessed up to 30 days
|
Duration of hospitalization following vascular intervention, measured in days from the date of the procedure until hospital discharge.
|
From the date of vascular intervention until hospital discharge, assessed up to 30 days
|
|
Contrast Volume
Zeitfenster: During Procedure
|
Total volume of contrast agent administered during the procedure, measured in milliliters (mL).
|
During Procedure
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Studienleiter: Sefa SURAL, MD, Toros University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- SRL-RADIUS-001
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Koronare Herzkrankheit
-
Zhejiang Cancer HospitalRekrutierungHepatic Artery Infusion | Lebermetastasen bei BrustkrebsChina
-
National Medical Research Center for Therapy and...Stupino Clinical Hospital, Moscow Region State Medical InstitutionAbgeschlossenUNTERSCHALTE CORONARY SYNDROMERussland
-
Medical University of WarsawRekrutierungANOCA | Angina ohne obstruktive Koronararterienerkrankung | Coronary Sinus ReduderPolen
Klinische Studien zur Radial and Ulnar Artery Access
-
Riphah International UniversityAbgeschlossenZervikale RadikulopathiePakistan
-
IRCCS San RaffaeleNoch keine Rekrutierung
-
University of Alabama at BirminghamJohns Hopkins University; Birmingham AIDS Outreach; AIDS UnitedAbgeschlossenHIV infektion | Verlust der HIV-Versorgung bis zur Nachsorge
-
Ataturk UniversityRekrutierungKnie Arthrose | Totale Knieendoprothetik | Postoperative SchmerztherapieTürkei (türkiye)